BMI Upgrades Pharmaceutical Sales Forecast In View Of New Medicine Listing

BMI View: The unpopularity of the Australian government's listing of previously deferred drugs, in addition to new drug listings, has pressured the government to reinstate the previous regulation. Over the long term, we do not expect the listing of new drugs to be sustainable given the country's precarious economic situation.

To read the full article, please choose one of the following options: